Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs > Rock Creek Pharmaceuticals Inc. (RCPI)

Anatabloc dosage

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
jcmeredith1 Member Profile
 
Followed By 5
Posts 187
Boards Moderated 0
Alias Born 10/02/09
160x600 placeholder
Rock Creek Pharmaceuticals Announces Presentation of Four Anatabine Projects at Neuroscience 2014 "PR Newswire (US)" - 10/23/2014 9:06:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 10/3/2014 4:30:42 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/24/2014 8:31:05 AM
Rock Creek Pharmaceuticals Receives New Dietary Ingredient Notification (NDIN) Response "PR Newswire (US)" - 9/12/2014 8:30:00 AM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 8/27/2014 4:23:53 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 8/22/2014 4:07:54 PM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 8/22/2014 4:00:28 PM
Amended Quarterly Report (10-q/a) "Edgar (US Regulatory)" - 8/18/2014 4:31:06 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/11/2014 5:12:27 PM
Rock Creek Pharmaceuticals Reports Second Quarter and Announces Clinical Update "PR Newswire (US)" - 8/11/2014 4:20:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/6/2014 4:38:09 PM
Rock Creek Pharmaceuticals Expands The Board with the Appointment of Two Independent Directors "PR Newswire (US)" - 8/6/2014 1:04:00 PM
Rock Creek Pharmaceuticals to Present at the Annual BioPharm America International Partnering Conference "PR Newswire (US)" - 8/4/2014 2:49:00 PM
Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical... "PR Newswire (US)" - 7/31/2014 3:31:00 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 7/16/2014 4:51:04 PM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 7/16/2014 6:00:34 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/11/2014 5:00:43 PM
Rock Creek Pharmaceuticals Issues Update On US Investigational New Drug Application "PR Newswire (US)" - 7/11/2014 4:30:00 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 7/10/2014 4:11:15 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/1/2014 9:01:29 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/2/2014 5:09:24 PM
Star Scientific Announces Corporate Name Change to Rock Creek Pharmaceuticals "PR Newswire (US)" - 6/2/2014 4:58:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/23/2014 4:56:14 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/12/2014 4:53:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/2/2014 4:52:40 PM
jcmeredith1   Saturday, 03/23/13 08:58:10 PM
Re: Pepsiman2001 post# 10129
Post # of 21071 
Anatabloc dosage

The company's research caused them to determine that the original dosage recommendation was not as "exact" as they wanted and did not fully account for weight.

Good luck with your health!


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist